Differentiating Fibromyalgia from other diseases: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) |
||
| Line 13: | Line 13: | ||
!Differentiating signs and symptoms | !Differentiating signs and symptoms | ||
!Differentiating labs | !Differentiating labs | ||
|- | |- | ||
|Rheumatoid arthritis | |Rheumatoid arthritis | ||
| Line 24: | Line 23: | ||
* Markers of systemic inflammation (ESR, CRP) are typically elevated. | * Markers of systemic inflammation (ESR, CRP) are typically elevated. | ||
|- | |- | ||
|SLE | |SLE | ||
| Line 32: | Line 30: | ||
| | | | ||
*Positive anti-Smith antibodies | *Positive anti-Smith antibodies | ||
|- | |- | ||
|[[Chronic fatigue syndrome]] | |[[Chronic fatigue syndrome]] | ||
| Line 48: | Line 45: | ||
*Diagnosis of exclusions | *Diagnosis of exclusions | ||
*Symptoms must present for more than 6 months | *Symptoms must present for more than 6 months | ||
|- | |- | ||
|Spondyloarthritis | |Spondyloarthritis | ||
| Line 59: | Line 55: | ||
* Bamboo spine on X-ray | * Bamboo spine on X-ray | ||
|- | |- | ||
|Polymyalgia rheumatica | |Polymyalgia rheumatica | ||
| Line 68: | Line 63: | ||
* An elevated erythrocyte sedimentation rate (ESR) OR C-reactive protein (CRP | * An elevated erythrocyte sedimentation rate (ESR) OR C-reactive protein (CRP | ||
* Response to corticosteroids | * Response to corticosteroids | ||
|- | |- | ||
|Osteoarthritis | |Osteoarthritis | ||
| Line 77: | Line 71: | ||
| | | | ||
* Xray of the involved joints demonstrate degenerative changes | * Xray of the involved joints demonstrate degenerative changes | ||
|- | |- | ||
|Hypothyroidism | |Hypothyroidism | ||
| Line 85: | Line 78: | ||
| | | | ||
*TSH is elevated and free T4 is low. | *TSH is elevated and free T4 is low. | ||
|- | |- | ||
|Myopathaies(polymyositis and dermatomyositis) | |Myopathaies(polymyositis and dermatomyositis) | ||
| Line 94: | Line 86: | ||
*Muscle biopsy confirms the diagnosis | *Muscle biopsy confirms the diagnosis | ||
*Elevated CPK enzyme | *Elevated CPK enzyme | ||
|- | |- | ||
|Neuropathy | |Neuropathy | ||
Revision as of 16:50, 16 June 2017
|
Fibromyalgia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Differentiating Fibromyalgia from other diseases On the Web |
|
American Roentgen Ray Society Images of Differentiating Fibromyalgia from other diseases |
|
Differentiating Fibromyalgia from other diseases in the news |
|
Risk calculators and risk factors for Differentiating Fibromyalgia from other diseases |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Fibromyalgia must be differentiated from other diseases that present with pain, fatigue and sleep disturbance, and symptoms of cognitive dysfunction and psychiatric disease such as rheumatoid arthritis, SLE, chronic fatigue syndrome, spondyloarthritis, polymyalgia rheumatica.[1][2][3][4][5]
Differentiating Fibromyalgia from other Diseases
Fibromyalgia must be differentiated from other diseases that present with pain, fatigue and sleep disturbance, and symptoms of cognitive dysfunction and psychiatric disease such as rheumatoid arthritis, SLE, chronic fatigue syndrome, spondyloarthritis, polymyalgia rheumatica.[1][2][3][4][5]
| Disease | Differentiating signs and symptoms | Differentiating labs |
|---|---|---|
| Rheumatoid arthritis |
|
|
| SLE |
|
|
| Chronic fatigue syndrome |
|
|
| Spondyloarthritis |
|
|
| Polymyalgia rheumatica |
|
|
| Osteoarthritis |
|
|
| Hypothyroidism |
|
|
| Myopathaies(polymyositis and dermatomyositis) |
|
|
| Neuropathy |
|
|
References
- ↑ 1.0 1.1 Goldenberg DL, Burckhardt C, Crofford L (2004). "Management of fibromyalgia syndrome". JAMA. 292 (19): 2388–95. doi:10.1001/jama.292.19.2388. PMID 15547167.
- ↑ 2.0 2.1 Clauw DJ (2014). "Fibromyalgia: a clinical review". JAMA. 311 (15): 1547–55. doi:10.1001/jama.2014.3266. PMID 24737367.
- ↑ 3.0 3.1 Borchers AT, Gershwin ME (2015). "Fibromyalgia: A Critical and Comprehensive Review". Clin Rev Allergy Immunol. 49 (2): 100–51. doi:10.1007/s12016-015-8509-4. PMID 26445775.
- ↑ 4.0 4.1 Häuser W, Burgmer M, Köllner V, Schaefert R, Eich W, Hausteiner-Wiehle C, Henningsen P (2013). "[Fibromyalgia syndrome as a psychosomatic disorder - diagnosis and therapy according to current evidence-based guidelines]". Z Psychosom Med Psychother (in German). 59 (2): 132–52. doi:10.13109/zptm.2013.59.2.132. PMID 23775553.
- ↑ 5.0 5.1 Eich W, Häuser W, Friedel E, Klement A, Herrmann M, Petzke F, Offenbächer M, Schiltenwolf M, Sommer C, Tölle T, Henningsen P (2008). "[Definition, classification and diagnosis of fibromyalgia syndrome]". Z Rheumatol (in German). 67 (8): 665–6, 668–72, 674–6. doi:10.1007/s00393-008-0404-4. PMID 19050952.